Chemoinformaics analysis of allyl Ethyl Ester (CAS) Ethylallylphthalate
| Molecular Weight | 234.251 | nRot | 5 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 9 |
| Exact Molecular Weight | 234.089 | nRing | 1 |
| Solubility: LogS | -2.799 | nHRing | 0 |
| Solubility: LogP | 2.93 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 34.2531 |
| nHD | 0 | BPOL | 19.2529 |
| QED | 0.579 |
| Synth | 1.825 |
| Natural Product Likeliness | -0.378 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.4 |
| MDCK | 0.0000374 |
| BBB | 0.35 |
| PPB | 0.792124 |
| VDSS | 0.884 |
| FU | 0.103251 |
| CYP1A2-inh | 0.983 |
| CYP1A2-sub | 0.251 |
| CYP2c19-inh | 0.943 |
| CYP2c19-sub | 0.107 |
| CYP2c9-inh | 0.672 |
| CYP2c9-sub | 0.666 |
| CYP2d6-inh | 0.697 |
| CYP2d6-sub | 0.486 |
| CYP3a4-inh | 0.598 |
| CYP3a4-sub | 0.166 |
| CL | 12.544 |
| T12 | 0.541 |
| hERG | 0.014 |
| Ames | 0.016 |
| ROA | 0.022 |
| SkinSen | 0.72 |
| Carcinogencity | 0.078 |
| EI | 0.987 |
| Respiratory | 0.053 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.73404 |